These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9840940)

  • 1. Genomic architecture and transcriptional activation of the mouse and human tumor susceptibility gene TSG101: common types of shorter transcripts are true alternative splice variants.
    Wagner KU; Dierisseau P; Rucker EB; Robinson GW; Hennighausen L
    Oncogene; 1998 Nov; 17(21):2761-70. PubMed ID: 9840940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours.
    Gayther SA; Barski P; Batley SJ; Li L; de Foy KA; Cohen SN; Ponder BA; Caldas C
    Oncogene; 1997 Oct; 15(17):2119-26. PubMed ID: 9366528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identical variant TSG101 transcripts in soft tissue sarcomas and various non-neoplastic tissues.
    Willeke F; Ridder R; Bork P; Klaes R; Mechtersheimer G; Schwarzbach M; Zimmer D; Kloor M; Lehnert T; Herfarth C; von Knebel Doeberitz M
    Mol Carcinog; 1998 Dec; 23(4):195-200. PubMed ID: 9869447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coamplification in tumors of KRAS2, type 2 inositol 1,4,5 triphosphate receptor gene, and a novel human gene, KRAG.
    Heighway J; Betticher DC; Hoban PR; Altermatt HJ; Cowen R
    Genomics; 1996 Jul; 35(1):207-14. PubMed ID: 8661122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tsg101 is upregulated in a subset of invasive human breast cancers and its targeted overexpression in transgenic mice reveals weak oncogenic properties for mammary cancer initiation.
    Oh KB; Stanton MJ; West WW; Todd GL; Wagner KU
    Oncogene; 2007 Aug; 26(40):5950-9. PubMed ID: 17369844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of TSG101 transcript abnormalities in human cancers.
    Trink B; Pai SI; Spunt SL; Raman V; Cairns P; Jen J; Gabrielson E; Sukumar S; Sidransky D
    Oncogene; 1998 May; 16(21):2815-8. PubMed ID: 9652749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
    McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and alternative splicing of the deleted in colorectal cancer (DCC) gene in normal and malignant tissues.
    Reale MA; Hu G; Zafar AI; Getzenberg RH; Levine SM; Fearon ER
    Cancer Res; 1994 Aug; 54(16):4493-501. PubMed ID: 8044801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of expressed sequences that include a gene for familial breast cancer (BRCA2) and other novel transcripts from a five megabase region on chromosome 13q12.
    Jacob AN; Kandpal G; Kandpal RP
    Oncogene; 1996 Jul; 13(1):213-21. PubMed ID: 8700550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis, identification and correction of some errors of model refseqs appeared in NCBI Human Gene Database by in silico cloning and experimental verification of novel human genes].
    Zhang DL; Ji L; Li YD
    Yi Chuan Xue Bao; 2004 May; 31(5):431-43. PubMed ID: 15478601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TSG101 is not mutated in lung cancer but a shortened transcript is frequently expressed in small cell lung cancer.
    Oh Y; Proctor ML; Fan YH; Su LK; Hong WK; Fong KM; Sekido YS; Gazdar AF; Minna JD; Mao L
    Oncogene; 1998 Sep; 17(9):1141-8. PubMed ID: 9764824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Truncated TSG101 transcripts in human leukemia and lymphoma cell lines.
    Hosokawa Y; Nagai E; Seto M
    J Cancer Res Clin Oncol; 2000 Feb; 126(2):79-84. PubMed ID: 10664246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and functional analysis of novel BRCA1 transcripts, including mouse Brca1-Iris and human pseudo-BRCA1.
    Pettigrew CA; French JD; Saunus JM; Edwards SL; Sauer AV; Smart CE; Lundström T; Wiesner C; Spurdle AB; Rothnagel JA; Brown MA
    Breast Cancer Res Treat; 2010 Jan; 119(1):239-47. PubMed ID: 19067158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of tumor susceptibility gene TSG101 in human papillary thyroid carcinomas.
    Liu RT; Huang CC; You HL; Chou FF; Hu CC; Chao FP; Chen CM; Cheng JT
    Oncogene; 2002 Jul; 21(31):4830-7. PubMed ID: 12101421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of TSG101 tumour susceptibility gene transcripts in cervical and endometrial cancers.
    Chang JG; Su TH; Wei HJ; Wang JC; Chen YJ; Chang CP; Jeng CJ
    Br J Cancer; 1999 Feb; 79(3-4):445-50. PubMed ID: 10027311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic characterization of the lysophosphatidic acid receptor gene, lp(A2)/Edg4, and identification of a frameshift mutation in a previously characterized cDNA.
    Contos JJ; Chun J
    Genomics; 2000 Mar; 64(2):155-69. PubMed ID: 10729222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Brca1 and splice variant Brca1delta11 RNA levels in mouse mammary gland during normal development and tumorigenesis.
    Mixon M; Kittrell F; Medina D
    Oncogene; 2000 Nov; 19(46):5237-43. PubMed ID: 11077440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human stearoyl-CoA desaturase: alternative transcripts generated from a single gene by usage of tandem polyadenylation sites.
    Zhang L; Ge L; Parimoo S; Stenn K; Prouty SM
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):255-64. PubMed ID: 10229681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of tuberous sclerosis 2 messenger RNA splice variants that are conserved and differentially expressed in rat and human tissues.
    Xiao GH; Jin F; Yeung RS
    Cell Growth Differ; 1995 Sep; 6(9):1185-91. PubMed ID: 8519695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of amphiregulin and Cripto-1 in mammary tumors from transgenic mice.
    Kenney NJ; Smith GH; Maroulakou IG; Green JH; Muller WJ; Callahan R; Salomon DS; Dickson RB
    Mol Carcinog; 1996 Jan; 15(1):44-56. PubMed ID: 8561865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.